The Kidney in Cardiometabolic Diseases
CME
1
|
MOC
1
|
Nursing
1
The Kidney in Cardiometabolic Diseases

Register for our complimentary webinar to learn about the kidney's role in cardiometabolic diseases such as diabetes, heart failure, atherosclerotic cardiovascular disease, and mineral and bone disorders. Diseases that affect renal function, as well as decreased kidney function due to aging, increase the risk of CVD, fractures and death.

Key topics include:

  • Understanding the bidirectional relationships between kidney disease and cardiometabolic disorders
  • Evaluating the effects of metabolic syndrome on renal and cardiovascular health.
  • Discussing the role of novel therapeutic agents in managing kidney disease associated with cardiometabolic conditions.
  • Identifying cardiometabolic risk factors that compel early screening and intervention.
  • Safety, efficacy, and clinical considerations in employing new pharmacological treatments for CKD patients with comorbid cardiometabolic conditions.
  • Managing mineral and bone disorders in CKD patients with cardiometabolic conditions.
  • Age-related decline in kidney function and its impact on cardiometabolic health.
Register
1
CME
Starts

9/12/2025

Expires

9/12/2026

Learning Objectives

Upon successful completion of The Kidney in Cardiometabolic Disease session, participants should be better able to:

  • Analyze the kidney's role in cardiometabolic diseases such as diabetes, heart failure, atherosclerotic cardiovascular disease, mineral and bone disorders, and diseases that affect renal function.
  • Distinguish the effects of decreased kidney function due to aging.


 

Target Audience

Endocrinologists, along with the broader endocrine care team, including nurses, nurse practitioners (NPs), physician assistants (PAs), and diabetologists are the target audience. Healthcare professionals (HCPs), including family and internal medicine physicians, nurses, NPs, and PAs are also the target audience

Speakers/Faculty

SPEAKERS
FACULTY

Maria Belalcazar, MD, FACE
Tenured Associate Professor in the Division of Endocrinology and Metabolism
University of Texas Medical Branch
Galveston, Texas

Lance Sloan, MD, MSE, FACE, FASN, FACP, FEAA, FASPC
Medical Director, Texas Institute for Kidney and Endocrine Disorders
Lufkin, TX

Commercial Support

This activity is supported by an independent educational grant from Merck.